Abstract
ObjectiveDS-8500a is a novel G protein-coupled receptor 119 agonist being developed for the treatment of type 2 diabetes. The study objective was to assess the efficacy and safety of DS-8500a...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have